Protagonist Therapeutics, Inc PTGX
- Icotyde — Plaque Psoriasis Approved
- Icotyde — Psoriatic Arthritis Phase 3
- Icotyde — Ulcerative Colitis Phase 3
- Icotyde — Crohn's Disease Phase 3
Home › Targets › IL-23 receptor
IL-23 receptor (1 companies · 4 programs)
Companies with an active program directed at IL-23 receptor.